A Polymeric Bioresorbable Vascular Scaffold Versus an Everolimus-Eluting Stent in ST-Segment Elevation Myocardial Infarction

Wernly, B.; Latib, A.; Ielasi, A.; Jung, C.

Journal of Invasive Cardiology 31(9): E271-E272

2019


ISSN/ISBN: 1557-2501
PMID: 31478894
Document Number: 698289
Bioresorbable vascular scaffold (BRS) devices deliver both short-term coronary artery support and drugs. This could potentially be advantageous in patients suffering from STEMI featuring large and necrotic thrombus-rich lesions, which are often associated with stent-related complications. We performed a meta-analysis comparing polymeric BRS vs everolimus-eluting stent in STEMI patients.

Document emailed within 1 workday
Secure & encrypted payments